Delivery Order SPE2DB20D9331-SPE2DB25FL0D9

Award Date 10/22/24
Potential Completion Date 10/23/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB25FL0D9
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $2,873.20 for the supply of HADLIMA PUSHTOUCH 40 MG/0.8 ML 0.8ML to the Defense Logistics Agency (DLA). The contract is a firm fixed-price award and is not associated with any set-aside designation.

DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program to provide a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated its capability to deliver a diverse array of specialized pharmaceutical products to the Department of Defense.

Generated 1/22/25, 12:48 AM